160 related articles for article (PubMed ID: 24118671)
1. Lomitapide at supratherapeutic plasma levels does not prolong the Qtc interval--results from a TQT study with moxifloxacin and ketoconazole.
Darpo B; Ferber G; Zhou M; Sumeray M; Sager P
Ann Noninvasive Electrocardiol; 2013 Nov; 18(6):577-89. PubMed ID: 24118671
[TBL] [Abstract][Full Text] [Related]
2. Ipragliflozin does not prolong QTc interval in healthy male and female subjects: a phase I study.
Zhang W; Smulders R; Abeyratne A; Dietz A; Krauwinkel W; Kadokura T; Keirns J
Clin Ther; 2013 Aug; 35(8):1150-1161.e3. PubMed ID: 23910665
[TBL] [Abstract][Full Text] [Related]
3. A randomized, crossover, placebo- and moxifloxacin-controlled study to evaluate the effects of bosutinib (SKI-606), a dual Src/Abl tyrosine kinase inhibitor, on cardiac repolarization in healthy adult subjects.
Abbas R; Hug BA; Leister C; Sonnichsen D
Int J Cancer; 2012 Aug; 131(3):E304-11. PubMed ID: 22065400
[TBL] [Abstract][Full Text] [Related]
4. Effect of nalmefene 20 and 80 mg on the corrected QT interval and T-wave morphology: a randomized, double-blind, parallel-group, placebo- and moxifloxacin-controlled, single-centre study.
Matz J; Graff C; Vainio PJ; Kallio A; Højer AM; Struijk JJ; Kanters JK; Andersen MP; Toft E
Clin Drug Investig; 2011 Nov; 31(11):799-811. PubMed ID: 21967071
[TBL] [Abstract][Full Text] [Related]
5. Effect of single doses of maraviroc on the QT/QTc interval in healthy subjects.
Davis JD; Hackman F; Layton G; Higgins T; Sudworth D; Weissgerber G
Br J Clin Pharmacol; 2008 Apr; 65 Suppl 1(Suppl 1):68-75. PubMed ID: 18333868
[TBL] [Abstract][Full Text] [Related]
6. Effects of sugammadex doses up to 32 mg/kg alone or in combination with rocuronium or vecuronium on QTc prolongation: a thorough QTc study.
de Kam PJ; van Kuijk J; Prohn M; Thomsen T; Peeters P
Clin Drug Investig; 2010; 30(9):599-611. PubMed ID: 20568829
[TBL] [Abstract][Full Text] [Related]
7. Levofloxacin can be used effectively as a positive control in thorough QT/QTc studies in healthy volunteers.
Taubel J; Naseem A; Harada T; Wang D; Arezina R; Lorch U; Camm AJ
Br J Clin Pharmacol; 2010 Apr; 69(4):391-400. PubMed ID: 20406223
[TBL] [Abstract][Full Text] [Related]
8. Eltrombopag does not affect cardiac repolarization: results from a definitive QTc study in healthy subjects.
Matthys G; Park JW; McGuire S; Wire MB; Zhang J; Bowen C; Williams D; Jenkins JM; Peng B
Br J Clin Pharmacol; 2010 Jul; 70(1):24-33. PubMed ID: 20642544
[TBL] [Abstract][Full Text] [Related]
9. Effects of atomoxetine on the QT interval in healthy CYP2D6 poor metabolizers.
Loghin C; Haber H; Beasley CM; Kothare PA; Kauffman L; April J; Jin L; Allen AJ; Mitchell MI
Br J Clin Pharmacol; 2013 Feb; 75(2):538-49. PubMed ID: 22803597
[TBL] [Abstract][Full Text] [Related]
10. A Phase I, Randomized, Double-Blinded, Placebo- and Moxifloxacin-Controlled, Four-Period Crossover Study To Evaluate the Effect of Gepotidacin on Cardiac Conduction as Assessed by 12-Lead Electrocardiogram in Healthy Volunteers.
Hossain M; Zhou M; Tiffany C; Dumont E; Darpo B
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223381
[TBL] [Abstract][Full Text] [Related]
11. A single-dose, crossover, placebo- and moxifloxacin-controlled study to assess the effects of neratinib (HKI-272) on cardiac repolarization in healthy adult subjects.
Hug B; Abbas R; Leister C; Burns J; Sonnichsen D
Clin Cancer Res; 2010 Aug; 16(15):4016-23. PubMed ID: 20647478
[TBL] [Abstract][Full Text] [Related]
12. Lenalidomide at therapeutic and supratherapeutic doses does not prolong QTc intervals in the thorough QTc study conducted in healthy men.
Chen N; Ye Y; Liu L; Reyes J; Assaf MS; Kasserra C; Zhou S; Palmisano M
Basic Clin Pharmacol Toxicol; 2013 Sep; 113(3):179-86. PubMed ID: 23639045
[TBL] [Abstract][Full Text] [Related]
13. A Thorough QT Study to Evaluate the Effects of Supratherapeutic Doses of Ledipasvir on the QTc Interval in Healthy Subjects.
German P; Mathias A; Brainard DM; Song Q; Ling J; Kearney BP
Clin Pharmacol Drug Dev; 2018 Aug; 7(6):641-651. PubMed ID: 29058821
[TBL] [Abstract][Full Text] [Related]
14. Effect of Retosiban on Cardiac Repolarization in a Randomized, Placebo- and Positive-controlled, Crossover Thorough QT/QTc Study in Healthy Men and Women.
Stier B; Fossler M; Liu F; Caltabiano S
Clin Ther; 2015 Jul; 37(7):1541-54. PubMed ID: 26138866
[TBL] [Abstract][Full Text] [Related]
15. Randomized, double-blind, crossover study to investigate the effect of rivaroxaban on QT-interval prolongation.
Kubitza D; Mueck W; Becka M
Drug Saf; 2008; 31(1):67-77. PubMed ID: 18095747
[TBL] [Abstract][Full Text] [Related]
16. Preladenant, a selective adenosine A₂A receptor antagonist, is not associated with QT/QTc prolongation.
Wang Z; Xuan F; Lin WH; Troyer MD; Tendolkar A; Cutler DL
Eur J Clin Pharmacol; 2013 Oct; 69(10):1761-7. PubMed ID: 23857248
[TBL] [Abstract][Full Text] [Related]
17. A single-dose placebo- and moxifloxacin-controlled study of the effects of temsirolimus on cardiac repolarization in healthy adults.
Boni JP; Leister C; Hug B; Burns J; Sonnichsen D
Cancer Chemother Pharmacol; 2012 Jun; 69(6):1433-42. PubMed ID: 22367193
[TBL] [Abstract][Full Text] [Related]
18. Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects.
Dixon R; Job S; Oliver R; Tompson D; Wright JG; Maltby K; Lorch U; Taubel J
Br J Clin Pharmacol; 2008 Sep; 66(3):396-404. PubMed ID: 18662287
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Effect of SPN-812 (Viloxazine Extended-Release) on QTc Interval in Healthy Adults.
Nasser A; Faison SL; Liranso T; Adewole T; Busse GD; Fava M; Kleiman RB; Schwabe S
J Clin Psychiatry; 2020 Oct; 81(6):. PubMed ID: 33049804
[TBL] [Abstract][Full Text] [Related]
20. Cardiac safety of indacaterol in healthy subjects: a randomized, multidose, placebo- and positive-controlled, parallel-group thorough QT study.
Khindri S; Sabo R; Harris S; Woessner R; Jennings S; Drollmann AF
BMC Pulm Med; 2011 May; 11():31. PubMed ID: 21615886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
